Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.

Merenich JA, Olson KL, Delate T, Rasmussen J, Helling DK, Ward DG; Clinical Pharmacy Cardiac Risk Service Study Group..

Pharmacotherapy. 2007 Oct;27(10):1370-8.

PMID:
17896892
2.

Outcomes of patients discharged from pharmacy-managed cardiovascular disease management.

Olson KL, Delate T, Rasmussen J, Humphries TL, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group..

Am J Manag Care. 2009 Aug;15(8):497-503.

3.

Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.

Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Kim JJ, Choo SJ, Song H, Chung CH, Lee JW, Park SW, Park SJ.

Circulation. 2008 Apr 22;117(16):2079-86. doi: 10.1161/CIRCULATIONAHA.107.750109.

4.

Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study.

Kauffman AB, Delate T, Olson KL, Cymbala AA, Hutka KA, Kasten SL, Rasmussen JR.

Clin Drug Investig. 2008;28(8):501-7.

PMID:
18598096
5.

All-cause mortality after drug-eluting stent implantation in African-Americans.

Poludasu S, Cavusoglu E, Khan W, Marmur JD.

Coron Artery Dis. 2008 Dec;19(8):551-7. doi: 10.1097/MCA.0b013e3283109033.

PMID:
19005289
6.

Factors associated with recurrent coronary events among patients with cardiovascular disease.

McConnell KJ, Olson KL, Delate T, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group..

Pharmacotherapy. 2009 Aug;29(8):906-13. doi: 10.1592/phco.29.8.906.

PMID:
19637943
7.

Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.

Tamburino C, Di Salvo ME, Capodanno D, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S.

Am J Cardiol. 2009 Jan 15;103(2):187-93. doi: 10.1016/j.amjcard.2008.08.059.

PMID:
19121434
8.

Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network.

Wiederkehr D, Berenson K, Casciano R, Stern L, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J.

Curr Med Res Opin. 2009 Sep;25(9):2317-25. doi: 10.1185/03007990903156061.

PMID:
19635042
9.

Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization.

Olson KL, Rasmussen J, Sandhoff BG, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group..

Arch Intern Med. 2005 Jan 10;165(1):49-54.

PMID:
15642874
10.
12.

Obesity paradox in patients with hypertension and coronary artery disease.

Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ.

Am J Med. 2007 Oct;120(10):863-70.

PMID:
17904457
13.

Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry.

Capodanno D, Di Salvo ME, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S, Tamburino C.

Catheter Cardiovasc Interv. 2009 Feb 15;73(3):310-6. doi: 10.1002/ccd.21845.

PMID:
19214964
14.

Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007.

Nakamura M, Yamashita T, Yajima J, Oikawa Y, Ogasawara K, Kirigaya H, Sagara K, Koike A, Sawada H, Aizawa T.

Hypertens Res. 2009 Oct;32(10):920-6. doi: 10.1038/hr.2009.114.

PMID:
19696780
15.

Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.

Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Abe M, Toma M, Tamura T, Haruna Y, Imai Y, Teramukai S, Fukushima M, Kita T.

Circulation. 2008 Sep 30;118(14 Suppl):S199-209. doi: 10.1161/CIRCULATIONAHA.107.735902.

16.
17.

Blood pressure level attainment among patients with coronary artery disease and uncontrolled blood pressure.

McConnell KJ, Morris JL, Delate T, Cymbala AA, Hornak R, Kauffman AB, McGinnis BD; Clinical Pharmacy Cardiac Risk Service Study Group..

Pharmacotherapy. 2011 Nov;31(11):1063-72. doi: 10.1592/phco.31.11.1063.

PMID:
22026394
18.

Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.

Weiss ES, Chang DD, Joyce DL, Nwakanma LU, Yuh DD.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):503-11, 511.e1-3. doi: 10.1016/j.jtcvs.2007.10.042.

19.

Advantages of myocardial revascularization after admission for critical limb ischemia in diabetic patients with coronary artery disease: data of a cohort of 564 consecutive patients.

Faglia E, Clerici G, Caminiti M, Quarantiello A, Curci V, Morabito A.

J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1030-6. doi: 10.2459/JCM.0b013e328306f2da.

PMID:
18799966
20.

Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.

Wiederkehr D, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Corbelli J.

Curr Med Res Opin. 2009 Sep;25(9):2327-34. doi: 10.1185/03007990903156087.

PMID:
19635046
Items per page

Supplemental Content

Support Center